Researcher Urges Stem Cell Trials In U.S. Instead Of China
This article was originally published in PharmAsia News
Executive Summary
A U.S. stem cell researcher is calling on fellow scientists to conduct their clinical trials in the United States instead of China. Wise Young of Rutgers University, who once began five clinical trials in China, told a conference he changed his mind about trials there when he discovered that some Americans had wanted to be in the trial so much they volunteered to go to China to be in them. Young urged U.S. trials even though he acknowledged they were cheaper to conduct in China. The problem, he said, was there is no source of funding for U.S. trials. (Click here for more